国药一致：10月30日召开董事会会议

Group 1 - The core point of the article is that China National Pharmaceutical Group Corporation (国药一致) held a board meeting on October 30, 2025, to review the proposal for increasing the registered capital of its subsidiary, China National Pharmaceutical Holdings Shantou Co., Ltd [1] - For the first half of 2025, the revenue composition of China National Pharmaceutical Group Corporation was as follows: 70.21% from pharmaceutical wholesale, 29.28% from pharmaceutical retail, and 0.51% from other products [1]